Focusing on innovative 3D cell technology products and services
Company News

New Approaches, More Possibilities | Pre-assembly of 3D Microcarriers Loaded with Cells for the Formation of 3D Functional Tissues

The pre-assembly of functional structures using 3D microcarriers loaded with mesenchymal stem cells (MSCs) provides a novel approach for establishing tissue engineering technologies based on clinical
16 2023/10

Interpretation of Standards | "Quality Management Standards for Raw Materials Used in the Production of Cell Therapy Products" (Group Standard)

Summary Description: CytoNiche, as a backbone unit of the association, participated in the drafting of this "standard."
26 2023/09

【Billion-Level Stem Cells Production】 On-site GMP Bootcamp Training Program was Successfully Held

CytoNiche Bio's inaugural "Billion-Level Stem Cell Production " bootcamp training program was successfully concluded at the CytoNiche’s Shanghai Center of Excellence (CoE) from August 15th to 22nd. This year, the bootcamp developed an interactive and immersive GMP setting to bring more than 20 technical elites from stem cell companies in China as well as, international participants. The bootcamp consisted of a mix of plenary training modules and lectures and interactive break-out sessions in smaller, more focused groups. The training was led by CytoNiche’s experts providing tips and feedback on scaling-up stem cells production and potential technical difficulties encountered by customers.
20 2023/09

CytoNiche's 3D FloTrix® Billion-Level Process Receives Authoritative Third-Party Quality Certification

Creating innovative original research products, technologies, and processes to achieve a breakthrough in the "quality" and "quantity" of three-dimensional cell culture.
13 2023/09

CytoNiche 3D Microcarrier Fully Enclosed Large-Scale Preparation of Umbilical Cord Mesenchymal Stem Cells Receives NIFDC Authority Certification!

Create innovative original research products, technologies, and processes to achieve a breakthrough in the "quality" and "quantity" of 3D cell culture.
11 2023/09

Cellular "Smart" Drugs, Future Therapies | CytoNiche: Never Stops, Empowering the Development of CGT Industry

To further understand the forefront of industry technology development, promote the translation of research results, and deepen technical exchanges across various fields, the "Cellular Smart Drugs, Future Therapies" 2023 inaugural (Beijing) Cell-based Pharmaceutical Industry Development Conference, and the 5th Anniversary Celebration of CytoNiche Biotech, co-sponsored by the Regenerative Medicine Professional Committee of the Chinese Association of Biotechnology and the Xieyi New Drug Talent Club, and co-organized by CytoNiche was grandly held at the Kun Tai Hotel in Beijing from August 26th to 27th.
28 2023/08
Previous page
Copyright: Beijing CytoNiche Biotechnology Co., Ltd.
Copyright: Beijing CytoNiche Biotechnology Co., Ltd.